Effects of pre-bronchoscopy administration of intravenous hydrocortisone in patients with chronic obstructive pulmonary disease

Not Applicable

• Conditions: chronic obstructive pulmonary disease.; chronic lower respiratory diseases; J40, J41,

• Registration Number: IRCT2015110922566N1
• Lead Sponsor: Vice chancellor for research,Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

inclusion criteria; diagnosed with chronic obstructive pulmonary disease and FEV1/FVC ratio less than 70% history of smoking the need of bronchoscopy for the diagnostic studies like hemoptysis, tuberculosis or lung mass.

exclusion criteria; diagnosis of asthma,cystic fibrosis oral or intravenous corticosteroid therapy or inhaled corticosteroid dose of 600 micrograms or more per day therapeutic bronchoscopy intubation.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vital sign. Timepoint: pre-bronchoscopy and 1 hour after bronchoscopy. Method of measurement: termometer,choronometer,sphygmanometer.;Cough. Timepoint: pre-bronchoscopy and 1 hour after bronchoscopy. Method of measurement: numboring score from 1 to 10.;Spirometery. Timepoint: pre-bronchoscopy and 1 hour after bronchoscopy. Method of measurement: spirometer.;Saturaton of blood oxygen. Timepoint: pre-bronchoscopy and 1 hour after bronchoscopy. Method of measurement: pulseoxymeter.